"The U.S. Food and Drug Administration today approved Viberzi (eluxadoline) and Xifaxan (rifaximin), two new treatments, manufactured by two different companies, for irritable bowel syndrome with diarrhea (IBS-D) in adult men and women.
(Generic versions may still be available.)
Zelnorm Consumer (continued)
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the Zelnorm (tegaserod maleate) Side Effects Center for a complete guide to possible side effects
PRECAUTIONS: Consult your pharmacist.
Additional Zelnorm Information
Zelnorm - User Reviews
Report Problems to the Food and Drug Administration
Get the latest treatment options.